Healthcare >> CEO Interviews >> February 19, 2001
RON BENTSUR joined Keryx Biopharmaceuticals, Inc., as Head of Investor
Relation in October 2000. Prior to this, Mr. Bentsur worked at Leumi &
Co. Underwriters Ltd., a subsidiary of the Bank Leumi Group, where he
was a Director of International and Technology Investment Banking. Prior
to this, Mr. Bentsur was Vice President, Investment Banking at ING
Barings Furman Selz in New York. Mr. Bentsur holds an MBA Honors degree
from the New York University Stern Graduate School of Business and a BA
Honors degree in Economics & Business Administration from the Hebrew
University, Jerusalem, Israel. Profile
Keryx Biopharmaceuticals?
Mr. Bentsur: Keryx Biopharmaceuticals is a biotechnology company that
has two main components.
